PSEUDOMONAS SPECIES CAUSING URINARY TRACT INFECTION AND ITS ANTIBIOGRAM AT A TERTIARY CARE HOSPITAL

Authors

  • Shobha Kl Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka, India.
  • Ramachandra L Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka, India.
  • Amita Shobha Rao Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka, India.
  • Anand Km Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka, India.
  • Gowrish Rao S Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i11.20002

Keywords:

Pseudomonas species, Urinary tract infection, Semi quantitative method

Abstract

 

 Objectives: Pseudomonas species cause urinary tract infection (UTI). This study was conducted to isolate Pseudomonas species causing significant bacteriuria and to analyze its antibiogram at a tertiary care hospital.

Methods: About 107 urine samples received in the laboratory from August 2015 to July 2016 having significant bacteriuria with Pseudomonas species were tested for antimicrobial activity. Samples were from both inpatients and patients attending as outpatients to a tertiary care hospital with different age groups and gender. Midstream urine samples were inoculated using a standard calibrated loop into blood agar and MacConkey agar following semi quantitative technique using Kass concept. MALD (Biomerio, ElToile, France) was used for speciation, and Vitex automated system (Biomerio, ElToile, France) was used for antibacterial sensitivity testing.

Results: About 107 urine samples contained Pseudomonas species by MALDI obtained from 69 male (64.48%) and 38 (35.51%) female patients. Inpatients were 90 (84.11%) and 17 (15.88%) outpatient department (OPD) patients. Isolation of Pseudomonas aeruginosa was from 90 samples (84.11%) and Pseudomonas putida in 17 (15.88%). Significant bacteriuria was more in the age group of ˃60 years in both genders. Susceptibility to gentamicin was 52 (48.59%), ceftazidime 56 (52.33%), and imipenem was 58 (54.20%). Organism was multidrug resistant in 49 (45.79%) samples.

Conclusion: P. aeruginosa remains the most common uropathogen among Pseudomonas species. Drug of choice for inpatients suffering from UTI by Pseudomonas species can be gentamicin and for patients attending OPD can be ceftazidime. Imipenem can be the reserve drug. Periodic antibiotic review is required for proper treatment of UTI.

Downloads

Download data is not yet available.

References

Tanvir R, Hafeez R, Hasnain S. Prevalence of multiple drug resistant Escherichia coli in patients of urinary tract infection registering at a diagnostic laboratory in Lahore, Pakistan. Pak J Zool 2012;44(3):707-12.

Wasnik DD. Prevalence and antibacterial susceptibility pattern of urinary tract infection causing human pathogenic Bacteria. Asian J Biomed Pharm Sci 2012;2(15):1-3.

Shah DA, Wasim S, Essa Abdullah F. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of urinary tract infections patients in Karachi, Pakistan. Pak J Med Sci 2015;31(2):341-5.

Eguchi H, Miyamoto T, Kuwahara T, Mitamura S, Mitamura Y. Infectious conjunctivitis caused by Pseudomonas aeruginosa isolated from a bathroom. BMC Res Notes 2013;6:245.

Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4.

Schaeffer AJ, Nicolle LE. Clinical Practice. Urinary tract infections in older men. N Engl J Med 2016;374(6):562-71.

Saperston KN, Shapiro DJ, Hersh AL, Copp HL. A comparison of inpatient versus outpatient resistance patterns of pediatric urinary tract infection. J Urol 2014;191 5 Suppl:1608-13.

Solanki R, Dawar R, Aggarwal DK, Rani H, Imdadi F, Jasuja S. Nonfermenting gram-negative bacilli and urinary tract infection-sorting the mystery of infections caused. J Med Microbiol Diagn 4:210. Doi:10.4172/2161-0703.1000210.

Iwashita Y, Enokiya T, Suzuki K, Yokoyama K, Yamamoto A, Ishikura K, et al. Arbekacin treatment of a patient infected with a Pseudomonas putida producing a metallo-beta-lactamase. J Intensive Care 2013;1:3.

Shobha KL, Rao GG, Kukkamalla AM. Prevalence of Non-Fermenters in Urinary Tract Infections in a Tertiary Care Hospital. Available from: http://www.webmedcentral.com. [Last accessed on 2011 Feb 07].

Chaudhary M, Payasi A. Comparative in vitro activity of supine against gram negative clinical isolates. Int J Pharm Pharm Sci 2015;7(7):198-202.

Biswas R, Rabbani R, Ahmed HS, Sarker MA, Zafrin N, Rahman MM. Antibiotic sensitivity pattern of urinary tract infection at a tertiary care hospital. Bangladesh Crit Care J 2014;2(1):21-4.

Shobha KL, D’Souza JS, Alva M, Anand KM, Rao G, Ramachandra L. Study of uropathogens and its antibiogram at a tertiary care hospital at coastal Karnataka. Ijppr Human 2015;4(2):100-9.

Syed MA, Ramakrishna PJ, Shaniya K, Arya B, Shakir VP. Urinary tract infections-an overview on the prevalence and the anti-biogram of gram negative uropathogens in a tertiary care centre in north Kerala, India. J Clin Diagn Res 2012;6(7):1192-5.

Divyashanthi CM, Aditiyakumar S, Bharathi N. Study of prevalence and antimicrobial susceptibility pattern of bacterial isolates in a tertiary care hospital. Int J Pharm Pharm Sci 2015;7 (1):185-90.

Moazami-Goudarzi1 S, Eftekhar F. Assessment of carbapenem susceptibility and multidrug-resistance in Pseudomonas aeruginosa burn isolates in Tehran. Jundishapur J Microbiol 2013;6(2):162-5.

Takeyama K, Kunishima Y, Matsukawa M, Takahashi S, Hirose T, Kobayashi N, et al. Multidrug-resistant Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infection. J Infect Chemother 2002;8(1):59-63.

Published

01-11-2017

How to Cite

Kl, S., R. L, A. S. Rao, A. Km, and G. R. S. “PSEUDOMONAS SPECIES CAUSING URINARY TRACT INFECTION AND ITS ANTIBIOGRAM AT A TERTIARY CARE HOSPITAL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 11, Nov. 2017, pp. 50-51, doi:10.22159/ajpcr.2017.v10i11.20002.

Issue

Section

Original Article(s)